Literature DB >> 7513678

Experience in treating benign prostatic hypertrophy with Sabal serrulata for one year.

I Romics1, H Schmitz, D Frang.   

Abstract

The authors treated 42 BPH patients with the Sabal extract Strogen forte for 12 months. The obstructive symptoms, residual volume, mean and maximum flow rates improved significantly by the 6th therapeutic month at the latest. The results seem to prove the effectiveness of the drug. Side effects have not been observed.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7513678

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  3 in total

1.  A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.

Authors:  Fatih Hizli; M Cemil Uygur
Journal:  Int Urol Nephrol       Date:  2007-01-04       Impact factor: 2.370

2.  Sabal serrulata extract (Strogen forte) in the treatment of symptomatic benign prostatic hyperplasia.

Authors:  J Kondás; V Philipp; G Diószeghy
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

3.  In vitro inhibition of testicular delta 5-3 beta-hydroxysteroid dehydrogenase and prostatic 5 alpha-reductase activities in rats and humans by strogen forte extract.

Authors:  I Tóth; M Szécsi; J Julesz; I Faredin; B Behnke
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.